These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37838323)

  • 1. Performance of capsule endoscopy for the detection of small intestinal neuroendocrine tumors in familial carcinoid: a prospective single-site study.
    Tang D; Lim R; Korman L; Forbes J; Ellsbury K; Auh S; Trivedi A; Chen CC; Hughes M; Wank S
    Gastrointest Endosc; 2024 Feb; 99(2):227-236. PubMed ID: 37838323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Added Diagnostic Value of
    Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
    J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
    Helali M; Heimburger C; Rohr S; Goichot B; Imperiale A
    Clin Nucl Med; 2016 Dec; 41(12):944-945. PubMed ID: 27749424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative
    Norlén O; Montan H; Hellman P; Stålberg P; Sundin A
    World J Surg; 2018 Feb; 42(2):498-505. PubMed ID: 29159606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
    Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
    Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
    Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
    Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
    Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
    Gangi A; Anaya DA
    Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in small bowel carcinoid diagnosis and staging: 18F-DOPA PET, capsule endoscopy and double balloon enteroscopy.
    Koornstra JJ; de Vries EG; Porte RJ
    Dig Liver Dis; 2009 Jul; 41(7):e35-8. PubMed ID: 18606578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Santhanam P; Taïeb D
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison between
    Piccardo A; Fiz F; Bottoni G; Ugolini M; Noordzij W; Trimboli P
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):595-605. PubMed ID: 34018606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.
    Haidar M; Shamseddine A; Panagiotidis E; Jreige M; Mukherji D; Assi R; Abousaid R; Ibrahim T; Haddad MM; Vinjamuri S
    Nucl Med Commun; 2017 Feb; 38(2):170-177. PubMed ID: 27922538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
    Ansquer C; Touchefeu Y; Faivre-Chauvet A; Leux C; Le Bras M; Régenet N; Fleury V; Maucherat B; Senellart H; Guyetant S; Carlier T; Scotet-Cérato E; Rauscher A; Frampas E; Kraeber-Bodéré F
    Clin Nucl Med; 2021 Mar; 46(3):181-186. PubMed ID: 33315677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).
    Hughes MS; Azoury SC; Assadipour Y; Straughan DM; Trivedi AN; Lim RM; Joy G; Voellinger MT; Tang DM; Venkatesan AM; Chen CC; Louie A; Quezado MM; Forbes J; Wank SA
    Surgery; 2016 Jan; 159(1):350-6. PubMed ID: 26454678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocol.
    Bonomi A; Fumagalli Romario U; Funicelli L; Conti G; Realis Luc M; Ceci F; Pozzi S; Radice D; Fazio N; Bertani E
    Langenbecks Arch Surg; 2024 Feb; 409(1):63. PubMed ID: 38363374
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ouvrard E; Mestier L; Boursier C; Lachachi B; Sahakian N; Chevalier E; Mikail N; Carullo J; Bando-Delaunay A; Walter T; Malouf GG; Addeo P; Poncet G; Sebag F; Lebtahi R; Goichot B; Taïeb D; Imperiale A
    J Nucl Med; 2022 Dec; 63(12):1865-1870. PubMed ID: 35589408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Tumor Uptake on
    De Rycke O; Perrier M; Ouvrard É; Mennetrey C; Lachachi C; Bando-Delaunay A; Morland D; Goichot B; Taieb D; Walter T; Cadiot G; Cros J; Hentic O; Ruszniewski P; Lebtahi R; Imperiale A; de Mestier L
    J Nucl Med; 2023 Nov; 64(11):1699-1705. PubMed ID: 37652547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT.
    de Hosson LD; van der Loo-van der Schaaf AM; Boellaard R; van Snick JH; de Vries EGE; Brouwers AH; Walenkamp AME
    Clin Nucl Med; 2019 Aug; 44(8):612-619. PubMed ID: 31274606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.